Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta‐analysis and meta‐regression analysis
B Galling, A Roldan, K Hagi, L Rietschel… - World …, 2017 - Wiley Online Library
Antipsychotic polypharmacy in schizophrenia is much debated, since it is common and
costly with unclear evidence for its efficacy and safety. We conducted a systematic literature …
costly with unclear evidence for its efficacy and safety. We conducted a systematic literature …
Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials
M Dold, C Li, D Gillies, S Leucht - European Neuropsychopharmacology, 2013 - Elsevier
Applying various psychopharmacological combination and augmentation strategies in
schizophrenia is common clinical practice. This meta-analysis evaluated the efficacy of …
schizophrenia is common clinical practice. This meta-analysis evaluated the efficacy of …
Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia
B Galling, JA Vernon, AK Pagsberg… - Acta Psychiatrica …, 2018 - Wiley Online Library
Objective To evaluate the efficacy and safety of antidepressant augmentation of
antipsychotics in schizophrenia. Methods Systematic literature search (PubMed/MEDLINE …
antipsychotics in schizophrenia. Methods Systematic literature search (PubMed/MEDLINE …
Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials
CU Correll, C Rummel-Kluge, C Corves… - Schizophrenia …, 2009 - academic.oup.com
Context: Despite lacking evidence for its safety and efficacy, antipsychotic cotreatment is
common in schizophrenia. Objective: To evaluate therapeutic and adverse effects of …
common in schizophrenia. Objective: To evaluate therapeutic and adverse effects of …
Augmentation strategies for clozapine refractory schizophrenia: a systematic review and meta-analysis
DJ Siskind, M Lee, A Ravindran… - Australian & New …, 2018 - journals.sagepub.com
Background: Although clozapine is the most effective medication for treatment refractory
schizophrenia, only 40% of people will meet response criteria. We therefore undertook a …
schizophrenia, only 40% of people will meet response criteria. We therefore undertook a …
Real-world effectiveness of antipsychotic monotherapy vs. polypharmacy in schizophrenia: to switch or to combine? A nationwide study in Hungary
Background Leading guidelines recommend antipsychotic (AP) monotherapy for
schizophrenia, nonetheless the combination of antipsychotics (polypharmacy) is common …
schizophrenia, nonetheless the combination of antipsychotics (polypharmacy) is common …
Efficacy and safety of aripiprazole augmentation of clozapine in schizophrenia: a systematic review and meta-analysis of randomized-controlled trials
M Srisurapanont, S Suttajit, N Maneeton… - Journal of Psychiatric …, 2015 - Elsevier
Limited options are available for clozapine-resistant schizophrenia and intolerable side
effects of clozapine. We conducted a systematic review of randomized-controlled trials …
effects of clozapine. We conducted a systematic review of randomized-controlled trials …
Efficacy of 42 pharmacologic cotreatment strategies added to antipsychotic monotherapy in schizophrenia: systematic overview and quality appraisal of the meta …
CU Correll, JM Rubio, G Inczedy-Farkas… - JAMA …, 2017 - jamanetwork.com
Importance Limited treatment responses in schizophrenia prompted the testing of combining
an antipsychotic drug treatment with a second psychotropic medication. A comprehensive …
an antipsychotic drug treatment with a second psychotropic medication. A comprehensive …
Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized …
H Tani, S Takasu, H Uchida, T Suzuki… - …, 2020 - nature.com
This systematic review and meta-analysis examined predictors of successful antipsychotic
dose reduction in schizophrenia. Prospective clinical trials and randomized controlled trials …
dose reduction in schizophrenia. Prospective clinical trials and randomized controlled trials …
Antipsychotic polypharmacy in schizophrenia: benefits and risks
TRE Barnes, C Paton - CNS drugs, 2011 - Springer
Antipsychotic polypharmacy refers to the co-prescription of more than one antipsychotic drug
for an individual patient. Surveys of prescribing in psychiatric services internationally have …
for an individual patient. Surveys of prescribing in psychiatric services internationally have …
相关搜索
- meta analysis antipsychotic augmentation
- monotherapy in schizophrenia antipsychotic augmentation
- meta analysis aripiprazole augmentation
- meta analysis efficacy and safety
- meta analysis clozapine in schizophrenia
- meta analysis benzodiazepine augmentation
- meta analysis dose reduction
- quality appraisal antipsychotic monotherapy
- meta analytic evidence
- antipsychotic polypharmacy management of schizophrenia
- antipsychotic polypharmacy evidence and recommendations
- antipsychotic polypharmacy benefits and risks
- benzodiazepine augmentation antipsychotic drugs
- patients with schizophrenia antidepressant augmentation
- meta analysis monotherapy in schizophrenia
- meta regression antipsychotic augmentation